A new study by researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) identifies a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages.
The study found that the substance, called Gdf-15, might be required for the development of early pancreatic tumors. The research also revealed that a molecule pronounced N-F-kappa-B (NF-kB) helps tumor cells produce Gdf-15. Read more . . .